| scholarly article | Q13442814 |
| P50 | author | Ulrich H Frey | Q62589042 |
| P2093 | author name string | Andrea Engler | |
| Matthias Thielmann | |||
| Jürgen Peters | |||
| Florian Dreja | |||
| Sarah Köberle | |||
| P2860 | cites work | Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs | Q24651962 |
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| MicroRNA regulation of cell lineages in mouse and human embryonic stem cells | Q24655106 | ||
| Current State of Circulating MicroRNAs as Cancer Biomarkers | Q26796328 | ||
| MicroRNAs in heart failure: Small molecules with major impact | Q27024714 | ||
| Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells | Q27860960 | ||
| Analyzing real-time PCR data by the comparative C(T) method | Q28131831 | ||
| MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction | Q28268501 | ||
| An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133 | Q28513095 | ||
| Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis | Q29547607 | ||
| Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma | Q29547772 | ||
| Export of microRNAs and microRNA-protective protein by mammalian cells | Q29614234 | ||
| MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins | Q29615034 | ||
| Biomarkers in acute cardiac disease: the present and the future | Q33997300 | ||
| Plasma levels of microRNA-499 provide an early indication of perioperative myocardial infarction in coronary artery bypass graft patients | Q34027681 | ||
| MicroRNA regulatory networks in cardiovascular development | Q34070117 | ||
| Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage | Q34189929 | ||
| Circulating miR-499 are novel and sensitive biomarker of acute myocardial infarction | Q35290689 | ||
| Expression Patterns of miRNA-423-5p in the Serum and Pericardial Fluid in Patients Undergoing Cardiac Surgery | Q35839869 | ||
| Plasma components affect accuracy of circulating cancer-related microRNA quantitation | Q35917691 | ||
| Coronary Artery-Bypass-Graft Surgery Increases the Plasma Concentration of Exosomes Carrying a Cargo of Cardiac MicroRNAs: An Example of Exosome Trafficking Out of the Human Heart with Potential for Cardiac Biomarker Discovery | Q36003227 | ||
| Diagnostic, functional, and therapeutic roles of microRNA in allergic diseases. | Q37080521 | ||
| Inhibition of human immunodeficiency virus gene amplification by heparin | Q37232781 | ||
| Serum microRNA-499 and microRNA-208a as biomarkers of acute myocardial infarction | Q37516362 | ||
| Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases | Q38040050 | ||
| miRNA423-5p regulates cell proliferation and invasion by targeting trefoil factor 1 in gastric cancer cells | Q38309261 | ||
| MicroRNAs in rheumatoid arthritis: altered expression and diagnostic potential | Q38545431 | ||
| Oncogenic role of microRNA-423-5p in hepatocellular carcinoma. | Q38811992 | ||
| Detection of gene expression by PCR amplification of RNA derived from frozen heparinized whole blood | Q40508387 | ||
| Heparinase treatment of heparin-contaminated plasma from coronary artery bypass grafting patients enables reliable quantification of microRNAs | Q41812954 | ||
| Heparin selectively affects the quantification of microRNAs in human blood samples | Q45236324 | ||
| Decreased expression of miR-133a but not of miR-1 is associated with signs of heart failure in patients undergoing coronary bypass surgery. | Q48004316 | ||
| miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas | Q48597370 | ||
| Comparison of miRNA signature versus conventional biomarkers before and after off-pump coronary artery bypass graft. | Q51057417 | ||
| Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. | Q54356342 | ||
| Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. | Q54408211 | ||
| MiR423-5p as a circulating biomarker for heart failure. | Q54439825 | ||
| Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery disease | Q61668954 | ||
| Effect of heparin on polymerase chain reaction. | Q64999521 | ||
| A rapid and simple method for reversing the inhibitory effect of heparin on PCR for HLA class II typing | Q72813587 | ||
| Reversal of RT-PCR inhibition observed in heparinized clinical specimens | Q73532917 | ||
| Heparin interference with reverse transcriptase polymerase chain reaction of RNA extracted from lungs after ischemia-reperfusion | Q73848270 | ||
| Heparinase treatment of RNA before quantitative real-time RT-PCR | Q75186407 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | coronary artery bypass surgery | Q186020 |
| P304 | page(s) | 1361 | |
| P577 | publication date | 2018-01-22 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Establishment of an easy and straight forward heparinase protocol to analyse circulating and myocardial tissue micro-RNA during coronary artery-bypass-graft surgery | |
| P478 | volume | 8 |
Search more.